Search | IOVS | ARVO Journals

Showing 1 – 20 of 30

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Outcomes of Eyes Lost To Follow up with Proliferative Diabetic Retinopathy That Recieved Combination Panretinal Photocoagulation and Intravitreal Anti-Vascular Endothelial Growth Factor.

Meera Sivalingam; Anthony Obeid; Devayu Parikh; Philip Brower; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2179 – F0242. doi:

ARVO Annual Meeting Abstract June 2021

Outcomes In Eyes Lost to Follow-up After Treatment with Steroid Injections for Retinal Pathology

JOHN W HINKLE; Raziyeh Mahmoudzadeh; Rachel Israilevich; Mirataollah Salabati; Anthony Obeid; Jason Hsu; Sunir J. Garg

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3302. doi:

ARVO Annual Meeting Abstract June 2021

Outcomes of Eyes with Retinal Vein Occlusion that are Lost to Follow-up after Anti-Vascular Endothelial Growth Factor Therapy

Mirataollah Salabati; Raziyeh Mahmoudzadeh; Jae-Chiang Wong; Dillan Patel; Samir N Patel; Rebecca Russ Soares; JOHN W HINKLE; Anthony Obeid; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3189. doi:

ARVO Annual Meeting Abstract June 2021

Systemic immunosuppression and risk of endophthalmitis after intravitreal anti-vascular endothelial growth factor injections

Julie Sun Kim; Samir N Patel; Philip P Storey; Anthony Obeid; Jason Hsu; Sunir J. Garg

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1362. doi:

ARVO Annual Meeting Abstract June 2021

Development of cystoid macular edema following rhegmatogenous retinal detachment surgery

Matthew Starr; Louis Cai; Michael Ammar; Luv Patel; Anthony Obeid; Ed Ryan; Claire Ryan; Antonio Capone; Geoffrey Emerson; Daniel Joseph; Dean Eliott; Omesh Gupta; Carl Regillo; Jason Hsu; Yoshihiro Yonekawa

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3657. doi:

ARVO Annual Meeting Abstract June 2020

Clinical Outcomes of Neovascular Glaucoma Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injection

Erik Mark Massenzio; David Xu; Turner David Wibbelsman; Anthony Obeid; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1339. doi:

ARVO Annual Meeting Abstract June 2020

Effectiveness of a Phone Call System On Mitigating Lost-To-Follow-Up In Patients Receiving Anti-VEGF therapy.

Michael J Ammar; Anthony Obeid; Luv Patel; Matthew Starr; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3076. doi:

ARVO Annual Meeting Abstract June 2020

Visual outcomes in Eyes Lost to Follow Up with Diabetic Macular Edema treated with Anti-Vascular Endothelial Growth Factor

Douglas Matsunaga; Connie M Wu; Anthony Obeid; Turner David Wibbelsman; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4878. doi:

ARVO Annual Meeting Abstract June 2020

Effect of Adjuvant Topical Dorzolamide-Timolol versus Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial

Samir N Patel; Jason Hsu; Jermey Wolfe; Chirag Shah; Eric Chen; Thomas Jenkins; Turner David Wibbelsman; Anthony Obeid; Mikel Mikhail; sunir garg; Allen C. Ho; Allen Chiang; Marc Spirin; James F Vander

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4213. doi:

ARVO Annual Meeting Abstract July 2019

Endophthalmitis following cataract surgery: visual outcomes and culture results

Hannah J Levin; Philip Storey; Maitri Pancholy; Samir N Patel; Turner D Wibbelsman; Anthony Obeid; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2033. doi:

ARVO Annual Meeting Abstract July 2019

Factors predicting distribution and practice patterns of retina providers across the United States (US)

Ravi Pandit; Turner D Wibbelsman; Thomas Jenkins; David Xu; Anthony Obeid; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3961. doi:

ARVO Annual Meeting Abstract July 2019

Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab

Jason Hsu; Anthony Obeid; Phoebe L Mellen; Turner D Wibbelsman; Michelle A. Konkoly; Michael R. Velez; Daniel B. Calem; Kareem Sioufi; Daniel Su; Philip Storey; Michael A. Klufas; Marc J. Spirn; Carl Regillo; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):80. doi:

ARVO Annual Meeting Abstract July 2019

Ocular hypertension following intravitreal injection of 0.7mg dexamethasone implant versus 2mg triamcinolone

Brandon Kuley; Philip Storey; Maitri Pancholy; Anthony Obeid; James Murphy; Jake Goodman; Turner D Wibbelsman; Carl Regillo; Allen Chiang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2645. doi:

ARVO Annual Meeting Abstract July 2019

Incidence and Timing of Delayed Retinal Breaks Following Acute Symptomatic Posterior Vitreous Detachment

Joshua Uhr; Anthony Obeid; Turner D Wibbelsman; Connie M Wu; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3967. doi:

ARVO Annual Meeting Abstract July 2019

Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion

Turner D Wibbelsman; Daniel B Calem; Anthony Obeid; Phoebe L Mellen; Michelle A. Konkoly; Michael R. Velez; Kareem Sioufi; Durga S Borkar; Ravi Pandit; Michael A. Klufas; Jason Hsu; Carl Regillo; Allen C Ho; Omesh P Gupta; Marc J. Spirn

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4057. doi:

ARVO Annual Meeting Abstract July 2019

Etiology, treatment and visual outcomes of patients with choroidal neovascularization under the age of 50

David Xu; Anthony Obeid; Hannah J Levin; Douglas Matsunaga; Kalla A Gervasio; Thomas L Jenkins; Ravi R Pandit; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5047. doi:

ARVO Annual Meeting Abstract July 2019

The utility of vitreous cultures in the management of endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents

Samir N Patel; Philip Storey; Maitri Pancholy; Anthony Obeid; Turner D Wibbelsman; Hannah Levin; Jason Hsu; Sunir Garg; James Dunn; James Vander

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2022. doi:

ARVO Annual Meeting Abstract July 2019

Sociodemographic disparities in presenting visual acuity of neovascular age related macular degeneration patients

Meera Diana Sivalingam; Kalla A Gervasio; Connie M Wu; Douglas Matsunaga; Joshua Uhr; Anthony Obeid; Turner D Wibbelsman; Hannah Levine; Ravi R Pandit; Thomas Jenkins; David Xu; Jason Hsu; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):69. doi:

ARVO Annual Meeting Abstract July 2019

Outcomes of Eyes Lost to Follow-Up with Neovascular Age Related Macular Degeneration Receiving Intravitreal Anti-VEGF

Rebecca Russ Soares; Phoebe L Mellen; Hannah Garrigan; Anthony Obeid; Turner D Wibbelsman; Durga S Borkar; Allen C Ho; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1197. doi:

ARVO Annual Meeting Abstract July 2018

Incidence of retinal artery occlusion following intravitreal anti-vascular endothelial growth factor injections

Xinxiao Gao; Durga S Borkar; Philip Storey; Daniel Su; Anthony Obeid; Kareem Sioufi; allen ho; Sunir Garg; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5457. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Outcomes of Eyes Lost To Follow up with Proliferative Diabetic Retinopathy That Recieved Combination Panretinal Photocoagulation and Intravitreal Anti-Vascular Endothelial Growth Factor.

Outcomes In Eyes Lost to Follow-up After Treatment with Steroid Injections for Retinal Pathology

Outcomes of Eyes with Retinal Vein Occlusion that are Lost to Follow-up after Anti-Vascular Endothelial Growth Factor Therapy

Systemic immunosuppression and risk of endophthalmitis after intravitreal anti-vascular endothelial growth factor injections

Development of cystoid macular edema following rhegmatogenous retinal detachment surgery

Clinical Outcomes of Neovascular Glaucoma Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injection

Effectiveness of a Phone Call System On Mitigating Lost-To-Follow-Up In Patients Receiving Anti-VEGF therapy.

Visual outcomes in Eyes Lost to Follow Up with Diabetic Macular Edema treated with Anti-Vascular Endothelial Growth Factor

Effect of Adjuvant Topical Dorzolamide-Timolol versus Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial

Endophthalmitis following cataract surgery: visual outcomes and culture results

Factors predicting distribution and practice patterns of retina providers across the United States (US)

Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab

Ocular hypertension following intravitreal injection of 0.7mg dexamethasone implant versus 2mg triamcinolone

Incidence and Timing of Delayed Retinal Breaks Following Acute Symptomatic Posterior Vitreous Detachment

Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion

Etiology, treatment and visual outcomes of patients with choroidal neovascularization under the age of 50

The utility of vitreous cultures in the management of endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents

Sociodemographic disparities in presenting visual acuity of neovascular age related macular degeneration patients

Outcomes of Eyes Lost to Follow-Up with Neovascular Age Related Macular Degeneration Receiving Intravitreal Anti-VEGF

Incidence of retinal artery occlusion following intravitreal anti-vascular endothelial growth factor injections

To View More...

You must be signed into an individual account to use this feature.